Tag: EPO

Cost-Utility Analysis Of Erythropoietin For Hemodialysis Patients

Bangkok, Thailand – Most patients receiving hemodialysis (HD) for end-stage renal disease (ESRD) currently receive erythropoietin (EPO) for anemia treatment. The goal of therapy is to achieve specific hemoglobin (Hb) target levels. Higher doses of EPO are used to attain higher

Posted in Value in Health Regional Issues Tagged with: , , , ,